Press release
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate diagnosis, allowing for timely intervention and better disease management. Pharmaceutical companies are focusing on developing targeted therapies, including monoclonal antibodies and small-molecule inhibitors, to provide long-term prophylaxis and acute treatment solutions. The growing prevalence of hereditary angioedema, coupled with rising healthcare expenditure and patient advocacy efforts, is further supporting market growth. Furthermore, regulatory approvals for innovative therapies and the emergence of subcutaneous and oral treatment options are enhancing patient adherence and convenience, creating a favorable outlook for the industry.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/hereditary-angioedema-market
Advantages of requesting a Sample Copy of the Report:
1) To understand how our report can bring a difference to your business strategy
2) To understand the analysis and growth rate in your region
3) Graphical introduction of global as well as the regional analysis
4) Know the top key players in the market with their revenue analysis
5) SWOT analysis, PEST analysis, and Porter's five force analysis
The report further explores the key business players along with their in-depth profiling
Shire, CSL Behring, Pharming Group, BioCryst Pharmaceuticals, Novartis, Sanofi, Valeant Pharmaceuticals
Hereditary Angioedema Market Segments:
◘ By Type: C1 Inhibitor, Bradykinin B2 Receptor Antagonists, Complement Inhibitors
◘ By Application: Genetic Disorders, Rare Diseases, Immunotherapy
Report Drivers & Trends Analysis:
The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Hereditary Angioedema Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.
Competitive Landscape Analysis:
In any market research analysis, the main field is competition. This section of the report provides a competitive scenario and portfolio of the Hereditary Angioedema Market's key players. Major and emerging market players are closely examined in terms of market share, gross margin, product portfolio, production, revenue, sales growth, and other significant factors. Furthermore, this information will assist players in studying critical strategies employed by market leaders in order to plan counterstrategies to gain a competitive advantage in the market.
Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.
» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/hereditary-angioedema-market
Key Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Hereditary Angioedema Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Hereditary Angioedema Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Hereditary Angioedema Market research report gives a thorough analysis of the current status of the Hereditary Angioedema Market's major players.
Key questions answered in the report:
➧ What will the market development pace of the Hereditary Angioedema Market?
➧ What are the key factors driving the Hereditary Angioedema Market?
➧ Who are the key manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Hereditary Angioedema Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Hereditary Angioedema Market?
➧ Who are the distributors, traders, and dealers of Hereditary Angioedema Market?
➧ What are the market opportunities and threats faced by the vendors in the Hereditary Angioedema Market?
➧ What are deals, income, and value examination by types and utilizations of the Hereditary Angioedema Market?
➧ What are deals, income, and value examination by areas of enterprises in the Hereditary Angioedema Market?
Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/hereditary-angioedema-market?license_type=license-single-user
Reasons To Buy The Hereditary Angioedema Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Market: An In-Depth Analysis here
News-ID: 4059360 • Views: …
More Releases from Orion Market Research

Data Center Robotics Market Set to Witness Significant Growth by 2033 | ABB Ltd. …
The global Data Center Robotics Market is estimated to be valued at USD 7.8 billion in 2024 and is projected to reach approximately USD 23.4 billion by 2033, growing at a CAGR of 13.1% from 2025 to 2033. This growth is driven by increasing demand for automation, energy efficiency, and operational reliability in data center management.
Data Center Robotics Market Overview
The Data Center Robotics Market is experiencing robust growth, fueled by…

Herbal Weight Loss Products Market: A Comprehensive Overview
In 2024, the market for Herbal Weight Loss Products Market was valued at USD 2.3 billion. It is anticipated to grow to USD 4.5 billion by 2033, with a CAGR of 8.5% over the period 2026-2033.
Herbal Weight Loss Products Market Overview
The Herbal Weight Loss Products Market is a dynamic segment within the broader health and wellness industry, focusing on products derived from natural plant sources designed to aid in…

Focal Segmental Glomerulosclerosis Market Revolutionary Insights into Trends, Dy …
Focal Segmental Glomerulosclerosis (FSGS) Market size was valued at USD 2.5 Billion in 2024 and is projected to reach USD 4.5 Billion by 2033, exhibiting a CAGR of 7.5% from 2026 to 2033.
Focal Segmental Glomerulosclerosis Market Overview
The Focal Segmental Glomerulosclerosis (FSGS) market is a specialized segment within the global nephrology healthcare sector. FSGS is a rare kidney disease characterized by scarring of the glomeruli, the filtering units of the kidneys,…

Erythropoietin Market Size Trends and Forecast by Application, Type, and Geograp …
Erythropoietin Market size at USD 11.5 Billion in 2024 and is forecast to achieve USD 17.7 Billion by 2033, registering a 4.9% CAGR from 2026 to 2033.
Erythropoietin Market Overview
Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures.…
More Releases for Hereditary
Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead.
Browse 153 Market Data Tables and 113 Figures spread through…
Hereditary Testing Market Size – Forecasts to 2026
The results analyzed by GME showed that the Global Hereditary Testing Market will grow with a CAGR value of 7.1 percent, to hit xx billion USD by 2026. During the forecast timeframe, growth is expected to be driven by growing expenditure on R&D activities and the rising incidence of chronic diseases worldwide. The development may be attributed to the advancement of genetic testing services and the growing demand for personalized…
Potential Opportunities of Hereditary Angioedema Treatment Market
The global hereditary angioedema treatment market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, "Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025." As per the report, the global hereditary angioedema treatment…
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes…
Hereditary Angioedema Market Current Overview by 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of…
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc.
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016.
Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html
Superior Healthcare…